星空体育官方入口网站网址大全-登录入口官网

#恶性胸腔积液#

16篇内容 | 960人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2198984, encodeId=5c182198984f4, content=<a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=a3e752852f4' target=_blank style='color:#2F92EE;'>#恩度#</a> <a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a> <a href='/topic/show?id=ccef1061227c' target=_blank style='color:#2F92EE;'>#恩沃利单抗#</a>, objectTitle=PD-L1高表达晚期肺腺癌合并恶性胸腔积液患者获益恩沃利单抗联合恩度治疗, objectType=article, longId=822000, objectId=662e822000a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-working-in-a-hospital-PSQT2U3.jpg, objectUrl=/article/show_article.do?id=662e822000a4, replyNumber=0, likeNumber=49, createdTime=2024-04-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=662e822000a4, moduleTitle=PD-L1高表达晚期肺腺癌合并恶性胸腔积液患者获益恩沃利单抗联合恩度治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=662e822000a4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1506793, encodeId=50671506e93f1, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=重组人血管内皮抑制素联合顺铂治疗乳腺癌恶性胸腔积液疗效观察, objectType=article, longId=221296, objectId=527022129651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=527022129651, replyNumber=0, likeNumber=80, createdTime=2021-12-01, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=527022129651, moduleTitle=重组人血管内皮抑制素联合顺铂治疗乳腺癌恶性胸腔积液疗效观察, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=527022129651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506792, encodeId=8db71506e9207, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=Thorax：硫酸乙酰肝素链造成恶性胸腔积液的抗凝环境, objectType=article, longId=185823, objectId=bff4185823d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bff4185823d2, replyNumber=0, likeNumber=63, createdTime=2020-01-08, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bff4185823d2, moduleTitle=Thorax：硫酸乙酰肝素链造成恶性胸腔积液的抗凝环境, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bff4185823d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506791, encodeId=8acf1506e91bd, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=JCLA：应用临床和分析参数诊断恶性胸腔积液, objectType=article, longId=175351, objectId=77b71e535101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77b71e535101, replyNumber=0, likeNumber=61, createdTime=2019-07-14, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77b71e535101, moduleTitle=JCLA：应用临床和分析参数诊断恶性胸腔积液, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=77b71e535101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506790, encodeId=0ecd1506e9074, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=Eur J Nucl Med Mol Imaging：诊断恶性胸腔积液的PET-CT评分, objectType=article, longId=164054, objectId=f86516405460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f86516405460, replyNumber=0, likeNumber=84, createdTime=2019-04-12, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f86516405460, moduleTitle=Eur J Nucl Med Mol Imaging：诊断恶性胸腔积液的PET-CT评分, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f86516405460)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506789, encodeId=596b1506e8926, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=2018美恶性胸腔积液指南：无呼吸困难等症状，则无须胸腔穿刺排液, objectType=article, longId=153026, objectId=4d1415302664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1415302664, replyNumber=0, likeNumber=54, createdTime=2018-11-09, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1415302664, moduleTitle=2018美恶性胸腔积液指南：无呼吸困难等症状，则无须胸腔穿刺排液, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4d1415302664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506788, encodeId=f1fc1506e8823, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=2018 ATS/STS/STR临床实践指南：恶性胸腔积液的管理, objectType=article, longId=150704, objectId=aad2150e049d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aad2150e049d, replyNumber=0, likeNumber=53, createdTime=2018-10-11, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aad2150e049d, moduleTitle=2018 ATS/STS/STR临床实践指南：恶性胸腔积液的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aad2150e049d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506787, encodeId=1f211506e87bc, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=2018 ERS/EACTS声明：恶性胸腔积液的管理, objectType=article, longId=145665, objectId=a3cc14566511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3cc14566511, replyNumber=0, likeNumber=60, createdTime=2018-08-03, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3cc14566511, moduleTitle=2018 ERS/EACTS声明：恶性胸腔积液的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a3cc14566511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506786, encodeId=0c331506e86d6, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=Lancet Respir Med：留置胸导管（AMPLE-2）对恶性胸腔积液进行激进性和症状引导性引流的比较, objectType=article, longId=145049, objectId=c42a1450492b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c42a1450492b, replyNumber=0, likeNumber=57, createdTime=2018-07-25, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c42a1450492b, moduleTitle=Lancet Respir Med：留置胸导管（AMPLE-2）对恶性胸腔积液进行激进性和症状引导性引流的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c42a1450492b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506785, encodeId=32071506e8587, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值, objectType=article, longId=144141, objectId=8865144141c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8865144141c3, replyNumber=0, likeNumber=57, createdTime=2018-07-13, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8865144141c3, moduleTitle=Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8865144141c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506784, encodeId=04641506e841c, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=PLos One：双能谱CT对良、恶性胸腔积液的鉴别诊断, objectType=article, longId=135138, objectId=e2cd13513863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2cd13513863, replyNumber=0, likeNumber=53, createdTime=2018-04-14, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2cd13513863, moduleTitle=PLos One：双能谱CT对良、恶性胸腔积液的鉴别诊断, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e2cd13513863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506783, encodeId=d07c1506e833b, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=CHEST：复发性恶性胸腔积液应如何治疗与管理？, objectType=article, longId=112288, objectId=dde3112288d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dde3112288d0, replyNumber=0, likeNumber=47, createdTime=2017-09-09, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dde3112288d0, moduleTitle=CHEST：复发性恶性胸腔积液应如何治疗与管理？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dde3112288d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506782, encodeId=a7351506e8286, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=Chest：非恶性胸腔积液在临床上可能有大用途！, objectType=article, longId=87018, objectId=93348e018f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93348e018f7, replyNumber=0, likeNumber=54, createdTime=2017-01-10, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93348e018f7, moduleTitle=Chest：非恶性胸腔积液在临床上可能有大用途！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93348e018f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506781, encodeId=85341506e816a, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=JAMA：恶性胸腔积液患者的疼痛和胸膜固定术疗效和胸管大小有关, objectType=article, longId=61032, objectId=8ad6610326c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad6610326c, replyNumber=0, likeNumber=54, createdTime=2015-12-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad6610326c, moduleTitle=JAMA：恶性胸腔积液患者的疼痛和胸膜固定术疗效和胸管大小有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8ad6610326c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506780, encodeId=1e391506e8000, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=《恶性胸腔积液诊断与治疗专家共识》解读, objectType=article, longId=36461, objectId=0f46364612e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f46364612e, replyNumber=0, likeNumber=66, createdTime=2014-06-18, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f46364612e, moduleTitle=《恶性胸腔积液诊断与治疗专家共识》解读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0f46364612e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506779, encodeId=8f211506e798d, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=恶性胸腔积液诊断与治疗专家共识解读, objectType=article, longId=35027, objectId=fe933502e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe933502e50, replyNumber=0, likeNumber=58, createdTime=2014-05-22, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe933502e50, moduleTitle=恶性胸腔积液诊断与治疗专家共识解读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe933502e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506778, encodeId=5efb1506e78ec, content=<a href='/topic/show?id=73fc529444d' target=_blank style='color:#2F92EE;'>#恶性胸腔积液#</a>, objectTitle=APJCP：IL-21联合CEA可提高恶性胸腔积液诊断率, objectType=article, longId=20382, objectId=930120382ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930120382ef, replyNumber=0, likeNumber=55, createdTime=2013-06-22, rootId=0, userName=ssnine, userId=1d3b9807093, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930120382ef, moduleTitle=APJCP：IL-21联合CEA可提高恶性胸腔积液诊断率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=930120382ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

恶性胸腔积液

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺腺癌# #恩度# #恶性胸腔积液# #恩沃利单抗#

PD-L1高表达晚期肺腺癌合并恶性胸腔积液患者获益恩沃利单抗联合恩度治疗

2024-04-17发表于陕西省

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

重组人血管内皮抑制素联合顺铂治疗乳腺癌恶性胸腔积液疗效观察

2021-12-01

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

Thorax：硫酸乙酰肝素链造成恶性胸腔积液的抗凝环境

2020-01-08

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

JCLA：应用临床和分析参数诊断恶性胸腔积液

2019-07-14

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

Eur J Nucl Med Mol Imaging：诊断恶性胸腔积液的PET-CT评分

2019-04-12

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

2018美恶性胸腔积液指南：无呼吸困难等症状，则无须胸腔穿刺排液

2018-11-09

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

2018 ATS/STS/STR临床实践指南：恶性胸腔积液的管理

2018-10-11

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

2018 ERS/EACTS声明：恶性胸腔积液的管理

2018-08-03

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

Lancet Respir Med：留置胸导管（AMPLE-2）对恶性胸腔积液进行激进性和症状引导性引流的比较

2018-07-25

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值

2018-07-13

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

PLos One：双能谱CT对良、恶性胸腔积液的鉴别诊断

2018-04-14

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

CHEST：复发性恶性胸腔积液应如何治疗与管理？

2017-09-09

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

Chest：非恶性胸腔积液在临床上可能有大用途！

2017-01-10

仁者大医 (审核中...)

前往app查看评论内容

#恶性胸腔积液#

JAMA：恶性胸腔积液患者的疼痛和胸膜固定术疗效和胸管大小有关

2015-12-24

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

《恶性胸腔积液诊断与治疗专家共识》解读

2014-06-18

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

恶性胸腔积液诊断与治疗专家共识解读

2014-05-22

ssnine (审核中...)

前往app查看评论内容

#恶性胸腔积液#

APJCP：IL-21联合CEA可提高恶性胸腔积液诊断率

2013-06-22

科室
- - 订阅+
  - 更多科室
工具
服务